ArticleNature cancer2023

WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma.

Alex Rialdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.